home libri books Fumetti ebook dvd top ten sconti 0 Carrello


Torna Indietro

bahri priya (curatore) - communicating about risks and safe use of medicines

Communicating about Risks and Safe Use of Medicines Real Life and Applied Research




Disponibilità: Normalmente disponibile in 15 giorni


PREZZO
118,98 €
NICEPRICE
113,03 €
SCONTO
5%



Questo prodotto usufruisce delle SPEDIZIONI GRATIS
selezionando l'opzione Corriere Veloce in fase di ordine.


Pagabile anche con Carta della cultura giovani e del merito, 18App Bonus Cultura e Carta del Docente


Facebook Twitter Aggiungi commento


Spese Gratis

Dettagli

Genere:Libro
Lingua: Inglese
Editore:

Adis

Pubblicazione: 06/2020
Edizione: 1st ed. 2020





Trama

At the core of this book lies the question how to approach medicines, risks and communication as a researcher - or anybody planning and evaluating a communication intervention, or wanting to understand communication events in private and the media. With a view to tackle current shortcomings of communication systems and processes for improved implementation, patient satisfaction and health outcomes, a multilayered approach is presented. This combines multiple data types and methods to obtain a wider and deeper understanding of the major parties and their interactions, as well as the healthcare, social and political contexts of information flows, how they interfere and which impact they have. Illustrated with real life experiences of safety concerns with medicines, worldwide active experts discuss the methods and contributions their disciplines can offer. With considerations on terminologies, tabulated overviews on communication types and outcomes, a patient-centred vision and plain language for non-medical readers, the book creates a platform for multidisciplinary collaborations amongst researchers as well as practitioners from communications, healthcare, the social sciences and pharmacovigilance. Importantly, it advocates for an active role of patients and highlights the achievements and aspirations of patient organisations. Finally, the book suggests establishing an inclusive discipline of humanities and epidemiology of medicinal product risk communication to realise full research potential. The authors are driven by the curiosity for communication as the most human behaviour, and as good health is amongst the basic human needs, medicinal product risk communication is an exciting research field of high global relevance.





Sommario

Foreword
Baruch Fischhoff

Preface: Guide for readers
Priya Bahri

Authors’ biographical notes

Overview of contents in chapters

1. A multilayered research framework for humanities and epidemiology of medicinal product risk communication
Priya Bahri

Part I: Medicines in real life as communication challenges
2. Hormonal contraceptives - Communication for risk awareness and informed choice, or a public scare?
Barbara Mintzes, Teresa Alves, with a contribution from Priya Bahri

3. COX-2 inhibitors - Communication of accumulating risk evidence and a product withdrawal
Amy Rogers, Kerr Grieve, Thomas M MacDonald, with a contribution from Sérgio Nishioka

4. Isotretinoin - Communication for preventing birth defects and alerting of an uncertain risk of suicide
Ineke (HJMJ) Crijns

5. Pandemic influenza vaccines - Communication of benefits, risks and uncertainties
Glen J Nowak, Emilie Karafillakis, Heidi Larson

Part II: Tackling the challenges – Methods for medicinal product risk communication research
6. Ethical frameworks
Ghislaine van Thiel

7. The cognitive and behavioural sciences
Sara Rubinelli, Nicola Diviani, Maddalena Fiordelli
 
8. The social sciences
Brian Taylor, Anne Moorhead

9. Rhetoric and science & technology studies
Mathias Møllebæk

10. Media science and practice
Glen J Nowak, Michael A Cacciatore

11. Social media research
Nabarun Dasgupta, Carly Winokur, Carrie E Pierce

12. Design science with a focus on user-centred evaluation of written information
Jörg Fuchs

13. Dissemination & implementation science
Elaine Morrato, Meredith Smith

14. Pharmacoepidemiology
Bert (HGM) Leufkens

15. Legal frameworks
Burkhard Sträter

16. From passive to active - Patients as contributors to medicinal product risk communication research
François Houÿez

Afterword: The dimension of communicating medicine risks in low- and middle-income countries
Nilima A Kshirsagar




Autore

Priya Bahri holds degrees in pharmacy and epidemiology, focused her PhD at Humboldt University of Berlin on healthcare quality management, and is trained in strategic communication and global health diplomacy. She worked in pharmacies and for projects of health insurance physicians’ associations and the German international development agency before joining the European Medicines Agency (EMA) in 1996 and specialising in pharmacovigilance. She is active for the Utrecht WHO Collaborating Centre for Pharmaceutical Policy and Regulation and also in learned societies, including as fellow of the International Society of Pharmacovigilance.










Altre Informazioni

ISBN:

9789811530128

Condizione: Nuovo
Dimensioni: 235 x 155 mm Ø 1060 gr
Formato: Copertina rigida
Illustration Notes:XXX, 504 p. 32 illus., 30 illus. in color.
Pagine Arabe: 504
Pagine Romane: xxx


Dicono di noi